Physician profile
Robin Piper
NPI 1356902563
$1,038.38
in general payments reported to CMS, 2019-2025
19 companies · $418 in 2025
The $418 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $129 · 2023: $297 · 2024: $194 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $909.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $223.36 | 2021-2025 | Aptima, Myosure Tissue Removal Device, Thinprep 2000 Processor |
| Myriad Women'S Health, INC. | $156.86 | 2023 | Myrisk |
| Exeltis, USA INC. | $124.46 | 2023-2025 | Slynd |
| Mayne Pharma Commercial LLC | $80.16 | 2023-2025 | |
| Pfizer INC. | $61.82 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $49.04 | 2025 | Myfembree, Gemtesa |
| Organon LLC | $48.20 | 2024-2025 | Nexplanon |
| Evofem Biosciences, INC. | $42.93 | 2025 | Phexxi, Solosec, Phexx |
| Exact Sciences Corporation | $40.63 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Coopersurgical, INC. | $40.60 | 2024-2025 | Endosee |
| Bayer Healthcare Pharmaceuticals INC. | $29.08 | 2024-2025 | |
| Sanofi Pasteur INC. | $23.70 | 2025 | |
| Astellas Pharma US INC | $20.15 | 2025 | Veozah |
| Boston Scientific Corporation | $18.96 | 2023 | |
| Aspira Women'S Health INC | $18.71 | 2024 | Ova1 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $15.42 | 2024 | |
| Millicent US INC | $15.04 | 2025 | Femlyv |
| Baxter Healthcare | $14.97 | 2023 | Tisseel |
| Abbvie INC. | $14.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Piper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.